Fluoxetine – do the benefits outweigh the risks in adolescent major depression?
- 1 January 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 6 (1), 147-150
- https://doi.org/10.1517/14656566.6.1.147
Abstract
Major depressive disorder probably occurs in approximately 5% of adolescents. In these adolescents, selective serotonin re-uptake inhibitors (SSRIs), other than fluoxetine, have shown limited benefit and may increase the risk of suicide. In the Treatment for Adolescents with Depression Study, treatment with fluoxetine of adolescents diagnosed with major depressive disorder, or with the combination of fluoxetine and cognitive behavioural therapy, was superior to placebo. Cognitive behavioural therapy alone was not shown to be superior to placebo. Of the patients in the study, 27% had at least minimal suicidal ideation at baseline, and this reduced to 9% at the end of the treatment period, with the reduction being similar in each of the treatment groups. There were more suicide-related adverse events in the patients treated with fluoxetine (15 of 216) than in patients not treated with fluoxetine (9 of 223). There were no actual suicides. Although further investigation of any association between fluoxetine and suicidal tendencies is clearly required, at present, fluoxetine is the only SSRI for which benefit has been clearly shown, and the benefits seem to outweigh the risks. Thus, fluoxetine should generally be the first choice drug of clinicians if they decide that antidepressant drug treatment is indicated in adolescents with major depressive disorder.Keywords
This publication has 5 references indexed in Scilit:
- Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished dataThe Lancet, 2004
- Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical TrialJournal of the American Academy of Child & Adolescent Psychiatry, 2002
- Psychosocial treatments for adolescent depressionClinical Psychology Review, 1999
- Cognitive-Behavioral Therapy of Depression and Depressive Symptoms During Adolescence: A Review and Meta-AnalysisJournal of the American Academy of Child & Adolescent Psychiatry, 1998
- A Double-blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Children and Adolescents With DepressionArchives of General Psychiatry, 1997